FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018223856> ?p ?o ?g. }

• W2018223856 endingPage "427" @default.
• W2018223856 startingPage "421" @default.
• W2018223856 abstract "Previous studies have shown a high rate of visualization of uptake and a decrease in serum thyroglobulin (Tg) after therapeutic doses of 131I in well-differentiated thyroid cancer patients with elevated thyroglobulinaemia but negative diagnostic 131I whole-body scan (DxWBS), but its therapeutic effect remains controversial. We evaluate the effect of therapeutic doses of 131I in patients with elevated thyroglobulin level but negative DxWBS.Among papillary thyroid carcinoma patients who underwent total or near-total thyroidectomy and remnant ablation with radioiodine during 1996 to 2000 in our hospital, the patients who showed elevated serum Tg levels and no abnormal uptake in DxWBS were selected. The selection for treatment or no treatment was decided according to the preference of the patients, considering side-effects of therapeutic doses of 131I, and the patients were thereafter studied retrospectively.Sixty papillary thyroid carcinoma patients with elevated thyroglobulinaemia but negative DxWBS were included. Twenty-eight patients were treated, and 32 were untreated.We compared serum Tg levels measured at less than 3 months before the administration of therapeutic doses of 131I or DxWBS with the levels at 6-12 months after administration between two groups. Comparable data on changes in serum Tg levels during TSH suppression (Tg-on) and those in hypothyroid phase (Tg-off) were available in 25 and 49 patients, respectively.Percentage decreases in both Tg-on and Tg-off levels of the treated group [41.2 (10.1-94.1)% and 37.0 (-176.6-88.4)%, respectively] were significantly higher than those of the untreated group [-43.6 (-180.1-7.3)% and -66.6 (-10644.2-39.1)%, respectively] (P < 0.001). The treated patients were followed-up for 23.8 +/- 19.6 months after the administration of therapeutic doses of 131I. In four cases, serum Tg levels converted to negative (< 1.0 ng/ml) both on and off T4 15-22 months after the administration of therapeutic doses of 131I, and negative serum Tg levels persisted for 24-70 months. However, negative conversion of elevated serum Tg levels was not observed in any of the untreated group. Post-treatment WBS revealed pathologic uptake in 12 of 28 cases (42.9%).This study revealed that the administration of therapeutic doses of 131I has a therapeutic effect, at least for palliation in short-term observation, considering the serum Tg level as an index of tumour burden, and that it can disclose previously undiagnosed lesion in some patients with differentiated thyroid cancer who show elevated thyroglobulin level but negative diagnostic 131I whole-body scan." @default.
• W2018223856 created "2016-06-24" @default.
• W2018223856 creator A5006158337 @default.
• W2018223856 creator A5019669804 @default.
• W2018223856 creator A5031957681 @default.
• W2018223856 creator A5040588122 @default.
• W2018223856 creator A5041165088 @default.
• W2018223856 creator A5042388176 @default.
• W2018223856 date "2003-03-18" @default.
• W2018223856 modified "2023-10-15" @default.
• W2018223856 title "Effects of therapeutic doses of ¹³¹I in thyroid papillary carcinoma patients with elevated thyroglobulin level and negative ¹³¹I whole‐body scan: comparative study" @default.
• W2018223856 cites W1607026867 @default.
• W2018223856 cites W1987585774 @default.
• W2018223856 cites W1998313745 @default.
• W2018223856 cites W2014664476 @default.
• W2018223856 cites W2023786802 @default.
• W2018223856 cites W2052158882 @default.
• W2018223856 cites W2062875350 @default.
• W2018223856 cites W2091271755 @default.
• W2018223856 cites W20955532 @default.
• W2018223856 cites W2152163562 @default.
• W2018223856 cites W2616027747 @default.
• W2018223856 cites W4232455183 @default.
• W2018223856 cites W4245762802 @default.
• W2018223856 doi "https://doi.org/10.1046/j.1365-2265.2003.01733.x" @default.
• W2018223856 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12641624" @default.
• W2018223856 hasPublicationYear "2003" @default.
• W2018223856 type Work @default.
• W2018223856 sameAs 2018223856 @default.
• W2018223856 citedByCount "75" @default.
• W2018223856 countsByYear W20182238562012 @default.
• W2018223856 countsByYear W20182238562013 @default.
• W2018223856 countsByYear W20182238562014 @default.
• W2018223856 countsByYear W20182238562015 @default.
• W2018223856 countsByYear W20182238562016 @default.
• W2018223856 countsByYear W20182238562017 @default.
• W2018223856 countsByYear W20182238562018 @default.
• W2018223856 countsByYear W20182238562019 @default.
• W2018223856 countsByYear W20182238562020 @default.
• W2018223856 countsByYear W20182238562022 @default.
• W2018223856 countsByYear W20182238562023 @default.
• W2018223856 crossrefType "journal-article" @default.
• W2018223856 hasAuthorship W2018223856A5006158337 @default.
• W2018223856 hasAuthorship W2018223856A5019669804 @default.
• W2018223856 hasAuthorship W2018223856A5031957681 @default.
• W2018223856 hasAuthorship W2018223856A5040588122 @default.
• W2018223856 hasAuthorship W2018223856A5041165088 @default.
• W2018223856 hasAuthorship W2018223856A5042388176 @default.
• W2018223856 hasConcept C102652120 @default.
• W2018223856 hasConcept C126322002 @default.
• W2018223856 hasConcept C134018914 @default.
• W2018223856 hasConcept C2777074255 @default.
• W2018223856 hasConcept C2778835679 @default.
• W2018223856 hasConcept C2779761222 @default.
• W2018223856 hasConcept C2993294228 @default.
• W2018223856 hasConcept C526584372 @default.
• W2018223856 hasConcept C71924100 @default.
• W2018223856 hasConcept C90924648 @default.
• W2018223856 hasConceptScore W2018223856C102652120 @default.
• W2018223856 hasConceptScore W2018223856C126322002 @default.
• W2018223856 hasConceptScore W2018223856C134018914 @default.
• W2018223856 hasConceptScore W2018223856C2777074255 @default.
• W2018223856 hasConceptScore W2018223856C2778835679 @default.
• W2018223856 hasConceptScore W2018223856C2779761222 @default.
• W2018223856 hasConceptScore W2018223856C2993294228 @default.
• W2018223856 hasConceptScore W2018223856C526584372 @default.
• W2018223856 hasConceptScore W2018223856C71924100 @default.
• W2018223856 hasConceptScore W2018223856C90924648 @default.
• W2018223856 hasIssue "4" @default.
• W2018223856 hasLocation W20182238561 @default.
• W2018223856 hasLocation W20182238562 @default.
• W2018223856 hasOpenAccess W2018223856 @default.
• W2018223856 hasPrimaryLocation W20182238561 @default.
• W2018223856 hasRelatedWork W1853885143 @default.
• W2018223856 hasRelatedWork W1981090278 @default.
• W2018223856 hasRelatedWork W1988357267 @default.
• W2018223856 hasRelatedWork W2030286795 @default.
• W2018223856 hasRelatedWork W2153521617 @default.
• W2018223856 hasRelatedWork W2168268608 @default.
• W2018223856 hasRelatedWork W2375126294 @default.
• W2018223856 hasRelatedWork W2418684463 @default.
• W2018223856 hasRelatedWork W2440959534 @default.
• W2018223856 hasRelatedWork W2181351535 @default.
• W2018223856 hasVolume "58" @default.
• W2018223856 isParatext "false" @default.
• W2018223856 isRetracted "false" @default.
• W2018223856 magId "2018223856" @default.
• W2018223856 workType "article" @default.